Earnings History Data for Fulgent Genetics, Inc. (FLGT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Fulgent Genetics, Inc.

Fulgent Genetics, Inc. is a technology company. It provide genetic testing services to physicians with clinically actionable diagnostic information. The Company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics, Inc. is headquartered in Temple City, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-08-2023	PM		FLGT	Fulgent Genetics, Inc.	1,170	-0.33	-0.59	0.59	Fulgent Genetics beats Q2 top and bottom line estimates; initiates Q3 and updates FY23 outlook [8/4/2023 7:12 AM]	38.94	-1.14 (-2.84%)	44.66	4.58 (11.43%)	28.27 - 65.17	755,057	140,000	18,330
Fulgent Genetics Q2 2023 Earnings Preview [8/3/2023 2:18 PM] Fulgent Genetics beats Q2 top and bottom line estimates; initiates Q3 and updates FY23 outlook [8/4/2023 7:12 AM]
05-05-2023	PM	9:05 AM ET (May 5)	FLGT	Fulgent Genetics, Inc.	863.15	-0.47	-0.68	4.93	Fulgent Genetics beats Q1 top and bottom line estimates; initiates Q2 and raises FY23 outlook [5/5/2023 7:14 AM]	33.90	5.38 (18.86%)	31.51	2.99 (10.48%)	28.27 - 65.17	604,788	150,000	5,686
Fulgent Genetics beats Q1 top and bottom line estimates; initiates Q2 and raises FY23 outlook [5/5/2023 7:14 AM]
28-02-2023	AH	After the close (Feb 28)	FLGT	Fulgent Genetics, Inc.	965.69	-0.71	-0.78	3.34	Fulgent Genetics Non-GAAP EPS of -$0.48 beats by $0.08, revenue of $67.7M beats by $8.13M [2/28/2023 4:13 PM]	31.91	-0.88 (-2.68%)	31.18	-1.61 (-4.91%)	28.53 - 65.32	211,007	180,000	21,423
Fulgent Genetics Non-GAAP EPS of -$0.48 beats by $0.08, revenue of $67.7M beats by $8.13M [2/28/2023 4:13 PM]
07-11-2022	AH	4:05 PM ET (Nov 7)	FLGT	Fulgent Genetics, Inc.	1,150	0.11	-0.02	3.93	Fulgent Genetics GAAP EPS of $0.06, revenue of $105.66M [11/7/2022 4:09 PM]	34.65	-0.88 (-2.46%)	32.25	-3.27 (-9.21%)	31.07 - 109.55	649,997	280,000	3,775
Fulgent Genetics GAAP EPS of $0.06, revenue of $105.66M [11/7/2022 4:09 PM] Fulgent Genetics acquires Fulgent Pharma for $100M [11/7/2022 4:37 PM] Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company [Nov-07-22 04:06PM] Fulgent Genetics Reports Third Quarter 2022 Financial Results [Nov-07-22 04:05PM] Fulgent Genetics, Inc. (FLGT) Beats Q3 Earnings and Revenue Estimates [Nov-07-22 05:55PM]
04-08-2022	AH	4:05 PM ET (Aug 4)	FLGT	Fulgent Genetics, Inc.	1,790	0.59	0.59	2.47	Fulgent Genetics Non-GAAP EPS of $0.78, revenue of $125.34M [8/4/2022 4:21 PM]	59.86	-3.88 (-6.09%)	59.86	0.0 (0.00%)	47.34 - 112.00	404,163	270,000	3,708
Fulgent Genetics Non-GAAP EPS of $0.78, revenue of $125.34M [8/4/2022 4:21 PM] Fulgent Genetics Reports Second Quarter 2022 Financial Results [Aug-04-22 04:05PM] Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors [Aug-04-22 08:00AM] Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox [Aug-04-22 08:00AM] Fulgent Genetics, Inc. (FLGT) Q2 Earnings and Revenues Beat Estimates [Aug-04-22 07:25PM]
03-05-2022	AH	4:05 PM ET (May 3)	FLGT	Fulgent Genetics	1,710	4.93	4.32	0.00	Fulgent Genetics Non-GAAP EPS of $5.08 beats by $1.22, revenue of $320.27M beats by $19.77M [5/3/2022 4:10 PM]	58.59	1.90 (3.35%)	59.85	3.16 (5.57%)	49.50 - 112.00	611,049	320,000	3,849
Fulgent Genetics Non-GAAP EPS of $5.08 beats by $1.22, revenue of $320.27M beats by $19.77M [5/3/2022 4:10 PM] Fulgent Genetics raises 2022 revenue guidance, but lowers income outlook [5/3/2022 5:46 PM] Fulgent Genetics' (NASDAQ:FLGT) investors will be pleased with their massive 746% return over the last three years [May-03-22 07:32AM] Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, California [May-03-22 08:00AM] Is Computer Programs and Systems (CPSI) Stock Undervalued Right Now? [May-03-22 09:40AM] Fulgent Genetics Announces Promotions and Leadership Updates [May-03-22 04:05PM] Fulgent Genetics Reports First Quarter 2022 Financial Results [May-03-22 04:05PM] Fulgent Genetics, Inc. (FLGT) Surpasses Q1 Earnings and Revenue Estimates [May-03-22 05:25PM]
23-02-2022	AH	4:05 PM ET (Feb 23)	FLGT	Fulgent Genetics, Inc.	1,900	3.34	2.66	6.12	Fulgent Genetics Non-GAAP EPS of $3.48 beats by $0.81, revenue of $251.7M beats by $60.6M [2/23/2022 4:10 PM]	61.20	1.07 (1.78%)	52.19	-7.94 (-13.20%)	51.00 - 122.93	1,018,867	526,060	45,627
Fulgent Genetics Non-GAAP EPS of $3.48 beats by $0.81, revenue of $251.7M beats by $60.6M [2/23/2022 4:10 PM] Fulgent Genetics invests $40M in Spatial Genomics' series A funding round [2/23/2022 4:19 PM] Fulgent Genetics stock drops 12% after hours despite beats on top and bottom lines [2/23/2022 5:26 PM] Fulgent, Epic Sciences collaborate on test for metastatic breast cancer [2/24/2022 12:07 PM] Fulgent Genetics Announces Strategic Investment in Spatial Genomics [Feb-23-22 04:05PM] Fulgent Genetics Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-23-22 04:05PM] Fulgent Genetics, Inc. (FLGT) Q4 2021 Earnings Call Transcript [Feb-23-22 11:00PM] EPIC SCIENCES AND FULGENT GENETICS COLLABORATE TO DELIVER DefineMBC RESULTS FOR METASTATIC BREAST CANCER PATIENTS [Feb-24-22 09:00AM]
09-11-2021	AH	4:05 PM ET (Nov 9)	FLGT	Fulgent Genetics, Inc.	2,520	3.93	1.30	1.95	Fulgent Genetics EPS beats by $0.80, beats on revenue [11/9/2021 4:10 PM]	79.37	0.75 (0.95%)	81.70	3.08 (3.92%)	32.00 - 189.89	779,593	390,000	16,038
Fulgent Genetics EPS beats by $0.80, beats on revenue [11/9/2021 4:10 PM] Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver for Early Liver Cancer Detection [Nov-08-21 08:00AM] Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences [Nov-09-21 08:00AM] Fulgent Genetics Reports Third Quarter Financial Results [Nov-09-21 04:05PM] Fulgent Genetics, Inc. Common Stock (FLGT) Q3 2021 Earnings Call Transcript [Nov-10-21 05:02AM] Fulgent Genetics Q3 Revenues More Than Double; Raises FY21 Outlook [Nov-10-21 07:04AM] Is Fulgent Genetics (FLGT) A Smart Long-Term Buy? [Nov-10-21 11:00AM]
09-08-2021	AH	4:05 PM ET (Aug 5)	FLGT	Fulgent Genetics, Inc.	2,680	2.47	2.54	0.17	Fulgent Genetics EPS misses by $0.12, misses on revenue [8/9/2021 4:11 PM]	97.37	-12.39 (-11.29%)	94.11	-15.65 (-14.26%)	26.03 - 189.89	1,942,563	840,000	47,013
Fulgent Genetics EPS misses by $0.12, misses on revenue [8/9/2021 4:11 PM] Fulgent Genetics shares slide after inking collaboration agreement with Helio Health [8/9/2021 4:11 PM] Fulgent Genetics acquires CSI Laboratories [8/9/2021 4:33 PM] Fulgent Genetics Announces Acquisition of CSI Laboratories [Aug-09-21 04:02PM] Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests [Aug-09-21 04:02PM] Fulgent Genetics Reports Second Quarter Financial Results [Aug-09-21 04:05PM] Fulgent Genetics, Inc. Common Stock (FLGT) Q2 2021 Earnings Call Transcript [Aug-10-21 01:01AM] Why Shares of Fulgent Genetics Are Plunging Today [Aug-10-21 02:34PM]
06-05-2021	AH	4:05 PM ET (May 6)	FLGT	Fulgent Genetics, Inc.	2,220	6.51	5.95	-0.08	Fulgent Genetics EPS beats by $0.89, beats on revenue [5/6/2021 4:09 PM]	74.59	1.58 (2.16%)	74.00	0.99 (1.36%)	13.40 - 189.89	2,409,281	1,150,000	37,178
Fulgent Genetics names new chief medical officer [5/6/2021 10:37 AM] Fulgent Genetics EPS beats by $0.89, beats on revenue [5/6/2021 4:09 PM] Why Shares of Fulgent Genetics Fell 20% in April [May-05-21 01:28PM] Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer [May-06-21 08:00AM] Fulgent Genetics, Inc. to Host Earnings Call [May-06-21 02:45PM] Fulgent Genetics Reports Record First Quarter Financial Results [May-06-21 04:05PM] Fulgent Genetics, Inc. Common Stock (FLGT) Q1 2021 Earnings Call Transcript [May-07-21 01:31AM] Why Investors Loved Fulgent Genetics' Q1 Results [May-07-21 06:08AM]
04-03-2021	AH	4:05 PM ET (Mar 4)	FLGT	Fulgent Genetics, Inc.	2,460	6.12	4.36	0.00	Fulgent Genetics EPS beats by $2.15, beats on revenue [3/4/2021 4:07 PM]	91.76	6.23 (7.28%)	111.39	25.86 (30.24%)	6.70 - 189.89	7,145,459	1,758,963	143,930
Fulgent surges in premarket after record revenue [3/5/2021 7:39 AM]
09-11-2020	AH	4:05 PM ET (Nov 9)	FLGT	Fulgent Genetics, Inc.	867.49	1.95	0.39	0.09	Fulgent Genetics EPS beats by $1.53, beats on revenue; raises FY20 outlook [11/9/2020 4:26 PM]	32.99	1.98 (6.39%)	36.00	4.99 (16.09%)	6.70 - 52.47	1,703,990	627,472	37,064

04-08-2020	AH	4:05 PM ET (Aug 4)	FLGT	Fulgent Genetics, Inc.	574.70	0.17	0.01	0.02	Fulgent Genetics EPS beats by $0.19, beats on revenue [8/4/2020 4:19 PM]	36.46	6.77 (22.82%)	38.30	8.61 (29.00%)	6.70 - 43.64	1,302,218	521,309	10,298